NCT04221945 2026-02-20KEYNOTE-A18Merck Sharp & Dohme LLCPhase 3 Completed1,060 enrolled 30 charts 1 FDA
NCT01851772 2021-01-12Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical CancerXoft, Inc.Phase NA Completed3 enrolled 6 charts
NCT01017549 2020-08-13Post Market Study Using the Xoft Axxent SystemXoft, Inc.Phase NA Completed44 enrolled 5 charts
NCT01045187 2012-08-01Feasibility Study Using the Xoft System for the Treatment of Endometrial CancerXoft, Inc.Phase NA Completed15 enrolled 5 charts
NCT00191100 2009-08-11Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the CervixEli Lilly and CompanyPhase 3 Completed515 enrolled 20 charts